Skip to main navigation Skip to search Skip to main content

Expression of Claudin-1, p53 and E-cadherin in pseudoepitheliomatous hyperplasia and squamous cell carcinoma of the head and neck

  • Jeonbuk National University
  • Woosuk University

Research output: Contribution to journalJournal articlepeer-review

Abstract

Background: Pseudoepitheliomatous hyperplasia (PEH) is a reactive proliferation of surface epithelium and can be confused with invasive squamous cell carcinoma (SCC) in head and neck biopsy specimens. To distinguish PEH from invasive SCC, immunohistochemical staining for claudin-1, E-cadherin and p53 was performed. Methods: Eighteen cases of PEH and 29 invasive SCC from head and neck lesions were immunostained and examined. Results: The invasive SCC showed increased staining of claudin-1 (p<0.001) and p53 (p<0.001) and decreased staining of E-cadherin (p=0.005) compared to the PEH specimens. The combined score calculated by adding the positive sum of claudin-1 and p53 and subtracting E-cadherin was useful for the differentiation of SCC from PEH (89.7% sensitivity and 88.9% specificity, p<0.001). Conclusions: The combined immunostaining for claudin-1, p53 and E-cadherin may help differentiate PEH from invasive SCC. The results of this study suggest that the increased expression of claudin-1 and p53 and the decreased expression of E-cadherin maybe markers for the aggressive growth of invasive SCC.

Original languageEnglish
Pages (from-to)287-293
Number of pages7
JournalKorean Journal of Pathology
Volume42
Issue number5
StatePublished - 2008

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Carcinoma
  • Claudin-1
  • E-cadherin
  • Hyperplasia
  • p53 protein
  • Squamous cell

Quacquarelli Symonds(QS) Subject Topics

  • Medicine

Fingerprint

Dive into the research topics of 'Expression of Claudin-1, p53 and E-cadherin in pseudoepitheliomatous hyperplasia and squamous cell carcinoma of the head and neck'. Together they form a unique fingerprint.

Cite this